A Study to Evaluate Screening Biomarkers for Lung Cancer
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Jacksonville, Florida: 20-012223
Sponsor Protocol Number: 20-012223
About this study
The purpose of this study is to evaluate new and complementary analytical MS technologies to identify and define the metabolic biomarkers for lung cancer.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Patients 18 or older years old.
- Patients with planned surgery for Non-small Cell Lung Cancer (NSCLC) confirmed cancer.
- Able to sign consent.
- Able to complete with specimen collection directions.
Exclusion Criteria:
- Individuals less than 18 years old.
- Patients with metastatic disease from another primary.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Jacksonville, Fla.
Mayo Clinic principal investigator Si Pham, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available